Top 4 Large-Cap Stocks In The Drug Manufacturers–Major Industry With The Highest EPS Estimates (AZN, NVS, ABT, GSK)

Below are the top large-cap drug manufacturers–major stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year. The earnings estimate for AstraZeneca Plc AZN for the next year ending December, 2011 is $6.49 per share. AZN's trailing-twelve-month ROE is 42.88%. Novartis AG NVS is expected to earn $5.03 per share over the next year ending December, 2011. NVS' trailing-twelve-month operating margin is 24.62%. Abbott Laboratories ABT is likely to earn $4.63 per share in the next year ending December, 2011. ABT's trailing-twelve-month ROE is 26.71%. GlaxoSmithKline Plc GSK may earn $4.00 per share in the next year ending December, 2011. GSK's trailing-twelve-month ROE is 48.54%. Trading Ideas.